ARTV
Artiva Biotherapeutics, Inc.Company with tickers: ARTV
CIK
1817241
CUSIP
04317A107
Shares Outstanding
24,716,672
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-10 | Huston Thad Allen | Chief Financial Officer | Award | 220,000 |
| 2026-02-18 | Sorg Elaine K. | SVP, US COMMERCIAL OPERATIONS | Award | 27,500 |
| 2026-02-18 | Sorg Elaine K. | SVP, US COMMERCIAL OPERATIONS | Other | 0 |
| 2026-02-18 | Huston Thad Allen | Chief Financial Officer | Other | 0 |
| 2026-02-15 | Raymon Heather | SVP, Research and Development | Tax | 1,521 |
| 2026-02-15 | Raymon Heather | SVP, Research and Development | Award | 46,000 |
| 2026-02-15 | Horan Christopher | Chief Tech Operations Officer | Tax | 2,187 |
| 2026-02-15 | Horan Christopher | Chief Tech Operations Officer | Award | 117,300 |
| 2026-02-15 | Bush Jennifer | COO, CLO, Secy, Compliance Off | Tax | 3,515 |
| 2026-02-15 | Bush Jennifer | COO, CLO, Secy, Compliance Off | Award | 117,300 |
| 2026-02-15 | Banerjee Subhashis | Chief Medical Officer | Award | 102,000 |
| 2026-02-15 | Aslan Fred | Director, President and CEO | Award | 366,850 |
| 2026-02-15 | Aslan Fred | Director, President and CEO | Tax | 14,600 |
| 2025-12-15 | Aslan Fred | Director, President and CEO | Sell | 3,187 |
| 2025-12-12 | Raymon Heather | SVP, Research and Development | Award | 67,253 |
| 2025-12-12 | Raymon Heather | SVP, Research and Development | Other | 18,239 |
| 2025-12-12 | Horan Christopher | Chief Tech Operations Officer | Award | 107,156 |
| 2025-12-12 | Horan Christopher | Chief Tech Operations Officer | Other | 77,519 |
| 2025-12-12 | Bush Jennifer | COO, CLO, Secy, Compliance Off | Award | 84,877 |
| 2025-12-12 | Bush Jennifer | COO, CLO, Secy, Compliance Off | Other | 41,039 |
| 2025-12-12 | Aslan Fred | Director, President and CEO | Other | 100,577 |
| 2025-12-12 | Aslan Fred | Director, President and CEO | Award | 869,136 |
| 2025-11-17 | Aslan Fred | Director, President and CEO | Sell | 6,375 |
| 2025-11-15 | Krishnamohan Neha | Chief Financial Officer | Tax | 3,490 |
| 2025-11-15 | Aslan Fred | Director, President and CEO | Tax | 6,347 |
| 2025-11-15 | Horan Christopher | Chief Tech Operations Officer | Tax | 1,899 |
| 2025-11-15 | Bush Jennifer | COO, CLO, Secy, Compliance Off | Tax | 3,055 |
| 2025-11-15 | Raymon Heather | SVP, Research and Development | Tax | 1,375 |
| 2025-10-17 | Aslan Fred | Director, President and CEO | Sell | 25,500 |
| 2025-08-15 | Bush Jennifer | COO, CLO, Secy, Compliance Off | Tax | 6,409 |
| 2025-08-15 | Horan Christopher | Chief Tech Operations Officer | Tax | 3,577 |
| 2025-08-15 | Aslan Fred | Director, President and CEO | Sell | 25,500 |
| 2025-08-15 | Aslan Fred | Director, President and CEO | Tax | 4,472 |
| 2025-08-15 | Raymon Heather | SVP, Research and Development | Tax | 1,639 |
| 2025-08-15 | Krishnamohan Neha | Chief Financial Officer | Tax | 5,813 |
| 2025-06-24 | HOUGEN ELIZABETH L | EVP, Finance & CFO | Award | 13,750 |
| 2025-06-24 | RA CAPITAL MANAGEMENT, L.P. | Director | Award | 13,750 |
| 2025-06-24 | MOORE ALISON | Chief Technical Officer | Award | 13,750 |
| 2025-06-24 | Baker Daniel G. | Director | Award | 13,750 |
| 2025-06-24 | Miralles Gines Diego | Director | Award | 13,750 |
| 2025-06-24 | Stoppel Laura | Director | Award | 13,750 |
| 2025-06-24 | DANIELS BRIAN | Director | Award | 13,750 |
| 2025-05-15 | Bush Jennifer | COO, CLO, Secy, Compliance Off | Tax | 1,937 |
| 2025-05-15 | Horan Christopher | Chief Tech Operations Officer | Tax | 1,341 |
| 2025-05-15 | Aslan Fred | Director, President and CEO | Tax | 4,472 |
| 2025-05-15 | Raymon Heather | SVP, Research and Development | Tax | 745 |
| 2025-05-15 | Krishnamohan Neha | Chief Financial Officer | Tax | 1,341 |
| 2025-04-08 | Banerjee Subhashis | Chief Medical Officer | Other | 0 |
| 2025-04-08 | Banerjee Subhashis | Chief Medical Officer | Award | 80,000 |
| 2025-04-08 | Banerjee Subhashis | Chief Medical Officer | Award | 50,000 |
| 2025-03-05 | Aslan Fred | Director, President and CEO | Award | 200,000 |
| 2025-02-26 | Raymon Heather | SVP, Research and Development | Award | 33,350 |
| 2025-02-26 | Horan Christopher | Chief Tech Operations Officer | Award | 60,000 |
| 2025-02-26 | Krishnamohan Neha | Chief Financial Officer | Award | 60,000 |
| 2025-02-26 | Bush Jennifer | COO, CLO, Secy, Compliance Off | Award | 86,650 |
| 2025-02-26 | Graef Thorsten | Chief Medical Officer | Award | 60,000 |
| 2025-01-28 | Baker Daniel G. | Director | Award | 27,500 |
| 2025-01-28 | Baker Daniel G. | Director | Other | 0 |
| 2024-10-21 | MOORE ALISON | Chief Technical Officer | Award | 27,500 |
| 2024-10-21 | MOORE ALISON | Chief Technical Officer | Other | 0 |
| 2024-09-12 | Raymon Heather | SVP, Research and Development | Award | 10,000 |
| 2024-09-12 | Bush Jennifer | COO, CLO, Secy, Compliance Off | Award | 50,000 |
| 2024-09-12 | Horan Christopher | Chief Tech Operations Officer | Award | 25,000 |
| 2024-09-12 | Krishnamohan Neha | Chief Financial Officer | Award | 50,000 |
| 2024-09-12 | Graef Thorsten | Chief Medical Officer | Award | 20,000 |
| 2024-07-22 | venBio Global Strategic Fund III, L.P. | 10% Owner | Other | 843,592 |
| 2024-07-22 | venBio Global Strategic Fund III, L.P. | 10% Owner | Other | 214,692 |
| 2024-07-22 | venBio Global Strategic Fund III, L.P. | 10% Owner | Other | 843,592 |
| 2024-07-22 | venBio Global Strategic Fund III, L.P. | 10% Owner | Buy | 416,666 |
| 2024-07-22 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% Owner | Other | 145,089 |
| 2024-07-22 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% Owner | Other | 145,089 |
| 2024-07-22 | GC Corp. | 10% Owner | Other | 330,095 |
| 2024-07-22 | GC Corp. | 10% Owner | Other | 667,185 |
| 2024-07-22 | GC Corp. | 10% Owner | Other | 667,185 |
| 2024-07-22 | GC Corp. | 10% Owner | Buy | 1,666,666 |
| 2024-07-22 | Aslan Fred | Director, President and CEO | Award | 228,905 |
| 2024-07-22 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 725,391 |
| 2024-07-22 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 564,372 |
| 2024-07-22 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 161,019 |
| 2024-07-22 | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 7,645,007 |
| 2024-07-22 | 5AM Partners VI, LLC | 10% Owner | Other | 214,692 |
| 2024-07-22 | 5AM Partners VI, LLC | 10% Owner | Buy | 833,333 |
| 2024-07-22 | 5AM Partners VI, LLC | 10% Owner | Other | 1,058,284 |
| 2024-07-22 | 5AM Partners VI, LLC | 10% Owner | Other | 843,592 |
| 2024-07-22 | Huh Yong-Jun | Director | Other | 330,095 |
| 2024-07-22 | Huh Yong-Jun | Director | Buy | 1,666,666 |
| 2024-07-22 | Huh Yong-Jun | Director | Other | 667,185 |
| 2024-07-22 | Huh Yong-Jun | Director | Other | 667,185 |
| 2024-07-18 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 0 |
| 2024-07-18 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 0 |
| 2024-07-18 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% Owner | Other | 0 |
| 2024-07-18 | Stoppel Laura | Director | Other | 0 |
| 2024-07-18 | Huh Yong-Jun | Director | Other | 0 |
| 2024-07-18 | Huh Yong-Jun | Director | Other | 0 |
| 2024-07-18 | Huh Yong-Jun | Director | Other | 0 |
| 2024-07-18 | Huh Yong-Jun | Director | Other | 348,837 |
| 2024-07-18 | Aslan Fred | Director, President and CEO | Other | 0 |
| 2024-07-18 | Aslan Fred | Director, President and CEO | Award | 343,811 |
| 2024-07-18 | venBio Global Strategic Fund III, L.P. | 10% Owner | Other | 0 |
| 2024-07-18 | venBio Global Strategic Fund III, L.P. | 10% Owner | Other | 0 |